Cel-Sci Corporation (CVM) Fundamentals

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
SHARE INFORMATION
Market Cap$ 216,201,770
Shares Outstanding43,327,008
Float41,642,964
Percent Float96.11%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.93
Latest Fiscal Date2021-09-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions251
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months1,550,173
Institutional Holdings Percent67.6%
Institutional Sold Previous 3 Months6,159,213
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months3,813
Insider Holdings Percent6.7
Insider Sold Previous 3 Months-
Insider Shares Owned2,894,571
TRADING INFO
52 Week High$ 27.28
52 Week Low$ 2.49
52 Week High Change$ -78.12
21 Day Moving Average$ 3.7033
21 Day Extended Moving Average$ 3.7843
50 Day Moving Average$ 3.325
50 Day Extended Moving Average$ 3.7125
200 Day Moving Average$ 6.8912
200 Day Extended Moving Average$ 6.57
10 Day Average Volume646,336
20 Day Average Volume969,643
30 Day Average Volume833,228
50 Day Average Volume2,124,498
Alpha0.055327
Beta2.1551
Standard Deviation0.425142
R20.057622
7 Day Price Change$ 1.27
7 Day Percent Change34.14%
21 Day Price Change$ 0.87
21 Day Percent Change21.12%
30 Day Price Change$ 1.95
30 Day Percent Change64.14%
Month to Date Price Change$ 1.34
Month to Date Percent Change36.71%
Quarter to Date Price Change$ 1.06
Quarter to Date Percent Change26.97%
180 Day Price Change$ -3.38
180 Day Percent Change-40.38%
200 Day Price Change$ -3.55
200 Day Percent Change-41.57%
Year to Date Price Change$ -2.11
Year to Date Percent Change-29.72%

Cel-Sci Corporation (CVM) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.30
Total Debt To Equity0.40
Int Coverage-29.40
Current Ratio8.30
Leverage Ratio1.40
Quick Ratio7.70
Long Term Debt To Capital0.24
VALUATION MEASURES
PE Ratio-5.10
Enterprise Value$ 172,401,049
Price to Sales0.00
Price to Free Cash-9.30
PE High Last 5 Years-2.30
Price To Book4.20
Price To Cash Flow0.00
PE Low Last 5 Years-8.70
Price to Tangible Book4.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-65.58
Return on Equity-98.91
Return on Capital-67.15

Cel-Sci Corporation (CVM) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEOGeert R. Kersten
Emplyoees-
Last AuditUQ
CIK0000725363
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Nanotechnology(541713)
CONTACT INFO
Address8229 Boone Boulevard
Suite 802
Vienna, VA 22182
Websitehttps://www.cel-sci.com
Facsimile+1 703 506-9471
Telephone+1 703 506-9460
Email-


Your Recent History
AMEX
CVM
Cel Sci
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.